
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
The American Journal of Managed Care
over 28 years ago
Physicians' Perceptions of Managed Careover 28 years ago
The Pharmacoeconomic Benefits of Cholesterol Reductionover 28 years ago
The Neonatologist as Primary Care Physicianover 28 years ago
An Update on the Treatment of Premenstrual Syndromeover 28 years ago
Physicians' Perceptions of Managed Care





